| Antimicrobial Agent | Susceptibility Profile | Clinical Interpretation |
|---|---|---|
| Amikacin | Sensitive | 16 |
| Cefepime | Sensitive | 8 |
| Ceftazidime | Sensitive | 2 |
| Ciprofloxacin | Sensitive | 0.12 |
| Colistin | Resistant | 4 |
| Gentamicin | Intermediate | 8 |
| Imipenem | Sensitive | 2 |
| Levofloxacin | Sensitive | 1 |
| Meropenem | Sensitive | <=0.25 |
| Minocycline | Resistant | 16 |
| Piperacillin/Tazobactam | Sensitive | 8 |
| Trimethoprim/Sulfamethoxazole | Resistant | 80 |
| Resistant Gene Track | Detection Methodology | NCBI Genome Accession |
|---|---|---|
| blaoxa51-like | PCR |